Risk of major hemorrhage for outpatients treated with warfarin

被引：0
|
作者：
Deborah A. McMahan
David M. Smith
Mark A. Carey
Xiao Hua Zhou
机构：
[1] the Richard L. Roudebush VAMC,the Division of Biostatistics, Department of Medicine
[2] the Division of General Internal Medicine,undefined
[3] Indiana University School of Medicine,undefined
[4] the Regenstrief Institute for Health Care,undefined
[5] Medical Group of Fort Wayne,undefined
来源：
Journal of General Internal Medicine | 1998年 / 13卷
关键词：
major hemorrhage; warfarin; alcohol abuse; chronic renal insufficiency; gastrointestinal hemorrhage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
OBJECTIVE: To determine the incidence of major hemorrhage among outpatients started on warfarin therapy after the recommendation in 1986 for reduced-intensity anticoagulation therapy was made, and to identify baseline patient characteristics that predict those patients who will have a major hemorrhage.
引用
收藏
页码：311 / 316
页数：5
相关论文
共 50 条
  • [21] BLEEDING IN OUTPATIENTS TREATED WITH WARFARIN - RELATION TO THE PROTHROMBIN TIME AND IMPORTANT REMEDIABLE LESIONS
    LANDEFELD, CS
    ROSENBLATT, MW
    GOLDMAN, L
    AMERICAN JOURNAL OF MEDICINE, 1989, 87 (02): : 153 - 159
  • [22] A 5-item score predicted risk for warfarin-associated major hemorrhage in patients with atrial fibrillation
    Nerella, Nishant
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (10)
  • [23] Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin
    Alonso, Alvaro
    Bengtson, Lindsay G. S.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    Chen, Lin Y.
    Lakshminarayan, Kamakshi
    STROKE, 2014, 45 (08) : 2286 - 2291
  • [24] In atrial fibrillation treated with warfarin, intracranial hemorrhage was associated with ischemic events
    Homoud, Munther K.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (08)
  • [25] Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine
    Denninger, JW
    Papakostas, GI
    Mahal, Y
    Merens, W
    Alpert, JE
    Nierenberg, AA
    Yeung, A
    Fava, M
    PSYCHOSOMATICS, 2006, 47 (04) : 348 - 352
  • [26] Title: No Risk of Increased Risk of Symptomatic Intracerebral Hemorrhage among Sub-therapeutic Warfarin Patients Treated with Tissue Plasminogen Activator
    Dugan, Nicholas M.
    Cochran, John W., II
    Callahan, Christa
    Krzywicki, Karen
    O'Mara, Susan
    Whitson, Maurie
    Montgomery, Robin
    Munoz, Rosalyn
    Mancini, Barbara
    Kitsantas, Panagiota
    Cheema, Jehanzeb
    Patel, Tejas H.
    STROKE, 2011, 42 (03) : E236 - E236
  • [27] Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage
    Witt, Daniel M.
    Clark, Nathan P.
    Martinez, Kerri
    Schroeder, Allison
    Garcia, David
    Crowther, Mark A.
    Ageno, Walter
    Dentali, Francesco
    Ye, Xiangyang
    Hylek, Elaine
    Delate, Thomas
    THROMBOSIS RESEARCH, 2015, 136 (05) : 1040 - 1044
  • [28] The risk of hemorrhage among patients with warfarin-associated coagulopathy
    Garcia, DA
    Regan, S
    Crowther, M
    Hylek, EM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 804 - 808
  • [29] Warfarin therapy in patients with atrial fibrillation: risk of intracranial hemorrhage
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (1): : 6 - 6
  • [30] Cerebral Hemorrhage, Warfarin, and Intravenous tPA The Real Risk Is Not Treating
    Alberts, Mark J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (24): : 2637 - 2639
12345